Nefazodone (NEF) is an antidepressive agent that was widely used in the treatment of depression until its withdrawal from the market, due to reports of liver injury and failure. NEF hepatotoxicity has been associated with mitochondrial impairment due to interference with the OXPHOS enzymatic activities, increased ROS generation and decreased antioxidant defenses. However, the mechanisms by which NEF induces mitochondrial dysfunction in hepatocytes are not completely understood. Here, we investigated the mitochondrial mechanisms affected upon NEF exposure and whether these might be linked to drug hepatotoxicity, in order to infer liabilities of future drug candidates.
Introduction
Nefazodone (NEF) is a phenylpiperazine derivative that belongs to the antidepressant class of serotonin noradrenergic re-uptake inhibitors (SNaRIs), approved in 1994 in the U.S.A (von Moltke et al., 1999) . as an alternative to avoid the unwanted side effects associated with the use of other antidepressants, including insomnia, nausea, sedation, cardiovascular toxicity or weight gain (Horst and Preskorn, 1998; Kent, 2000) . Despite its efficacy in the treatment of depression, NEF was shown to be toxic, and four cases of hepatic injury were reported in NEF-treated patients in 1999 (Aranda-Michel et al., 1999; Lucena et al., 1999) . Later, Bristol-Myers Squibb decided to stop marketing the drug in the U.S.A. due to the emergence of several hepatotoxicity cases following depression treatment (Aranda-Michel et al., 1999; Choi, 2003; Eloubeidi et al., 2000) . As a consequence of NEF treatment, hepatotoxic symptoms were common and included jaundice, dark urine, clay colored stool and increased plasma levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin and prothrombin time (Aranda-Michel et al., 1999; Lucena et al., 1999) . NEF hepatotoxic effects have been previously associated with the inhibition of cytochrome P450 3A4 (CYP3A4), since NEF treatment in human hepatocytes and human liver microsomes in the presence of the non-selective inhibitor of P450, 1-aminobenzotriazole (ABT), resulted in a significant decrease in protein synthesis together with a decrease in NEF metabolism (Kostrubsky et al., 2006) . The same work showed that NEF treatment resulted in inhibition of both bile acid transport, via the bile salt export pump (BSEP) present in membrane vesicles, and the canalicular transport in cultured human hepatocytes (Kostrubsky et al., 2006) . NEF was also shown to directly impair hepatic mitochondrial function through inhibition of OXPHOS complexes, particularly complex I (Dykens et al., 2008; Nadanaciva et al., 2007) . Although mitochondrial dysfunction seems to be a major player behind NEF hepatotoxicity, there are only a few reports describing the possible mechanisms involved (Dykens et al., 2008; Kim et al., 2012; Swiss et al., 2013; Xu et al., 2008) . Dykens et al., reported that NEF treatment resulted in a decreased mitochondrial transmembrane electric potential (DJ m ), a marked reduction in the intracellular levels of reduced glutathione, and a rise in the levels of reactive oxygen species (ROS) in primary cultures of human hepatocytes (Dykens et al., 2008) . A dramatic reduction in oxygen consumption by isolated rat liver mitochondria incubated with NEF was also observed in the same study, followed by an increase in the extracellular acidification rate (ECAR) (Dykens et al., 2008) . Further evidence regarding mitochondrial involvement in the reported NEF toxicity came from observation of depleted ATP levels in HepG2 cells upon NEF treatment (Dykens et al., 2008) .
Considering the mitochondrial role in the regulation and amplification of apoptotic signaling pathways (Vega-Naredo et al., 2015) , NEF-induced mitochondrial dysfunction may be associated with activation of cell death pathways. The main objective of the present work was to characterize NEF hepatotoxic mechanisms on a hepatocyte-like cell, the human hepatocellular carcinoma (HepG2) cell line, with focus on mitochondria-associated pathways commonly associated with drug cytotoxicity, which may be used to predict liabilities of future drug candidates. The HepG2 cell line has been extensively used as a preclinical model to assess drug safety. Despite their lack of xenobiotic metabolic capacity, altered bioenergetic phenotype and lack of polarization, which would in theory covert HepG2 cells into a poor model to study drug hepatotoxicity, the tumorigenic bioenergetic phenotype of HepG2 cells may be an advantage over primary hepatocytes since the Warburg effect confers cancer cells the additional ability to obtain ATP from glycolysis, which may be relevant to drug hepatotoxicity (Kamalian et al., 2015) .
Materials and methods

Reagents
Fetal Bovine Serum (FBS), trypsin-EDTA, Penicillin-Streptomycin-Amphotericin B, tetramethylrhodamine methyl ester (TMRM þ ), MitoSOX Red, calcein acetoxymethyl ester (Calcein-AM, or CAM), and Propidium Iodide (PI), were purchased from Invitrogen (Carlsbad, CA, USA). Dulbecco's Modified Eagle's Medium (DMEM)-high glucose (D5648) and DMEM without glucose (D5030), radio immunoprecipitation assay (RIPA) buffer, DLdithiothreitol (DTT), protease inhibitor cocktail (PIC), phosphatase inhibitor cocktail 2, pNA, Ponceau S, Bradford Reagent, NEF, dimethyl sulfoxide (DMSO), sulforhodamine B (SRB) reagent and Hoechst 33342 were obtained from Sigma-Aldrich (St. Louis, MO, USA). Pierce BCA assay kit was purchased from ThermoFisher Scientific (Lafayette, CO, USA). The molecular weight standard (Catalog# MB09002) was purchased from NZYTech (Lisbon, Portugal). BSA used as a blotting-grade blocker and 2x Laemmli Sample Buffer were purchased from Bio-Rad (Hercules, CA, USA). Caspases-3 and -9 substrates were purchased from Calbiochem (San Diego, CA, USA). All other reagents and chemical compounds used were of the highest degree of purity commercially available.
Cell culture and treatments
The HepG2 cell line was kindly provided by Dr. Carlos Palmeira (Center for Neuroscience and Cell Biology, University of Coimbra). Cells were cultured in high glucose DMEM supplemented with 10% tissue culture dishes at 37 C in a humidified atmosphere of 5% CO 2 . For some assays, cells were also cultured in OXPHOS medium, consisting of DMEM supplemented with 6 mM glutamine, 5 mM HEPES, 10 mM galactose, 44 mM sodium bicarbonate, 1 mM sodium pyruvate, 10% fetal bovine serum and 1% penicillin-streptomycinamphotericin B. To adapt HepG2 cells to grow in the OXPHOS medium the glucose concentration in the medium was gradually decreased in 25% steps, for 3 passages, by mixing OXPHOS medium with glucose-containing DMEM. The cells were passed in 100% OXPHOS medium at least 3 times before any experiments were performed (Swiss and Will, 2011) .Where indicated, cells were treated with NEF prepared in DMSO, which was kept refrigerated as a stock solution at 19.7 mM up to 1 month after preparation.
Analysis of NEF cytotoxicity by the SRB assay
The sulforhodamine B colorimetric assay allows the determination of cell density and is based on the measurement of cellular protein content (Vichai and Kirtikara, 2006 Incubation was performed for 15e20 min, protected from light, at room temperature. The fluorescence of both probes was quantified through flow cytometry after running 20,000 cells at a medium/high sample flow rate on a FACSCalibur flow cytometer (BD Biosciences, San Jose, California, USA).
Analysis of caspases 9 and 3-like activities
To evaluate caspase 9 and 3-like activities, cells were seeded in 60 cm 2 dishes at a density of 1.7 Â 10 6 cells/dish. Cells were treated with 20 or 50 mM NEF for 24 or 48 h, and at the end of treatment, both floating and adherent cells were collected. The culture medium in the dishes was centrifuged twice at 1000Âg for 5 min, and cell pellets were resuspended in assay buffer (50 mM HEPES pH 7.4; 100 mM NaCl; 0.1% CHAPS; 10% glycerol; 10 mM DTT). Adherent cells were washed with PBS (0.137 M NaCl, 2.7 mM KCl, 1.4 mM KH 2 PO 4 , 0.01 M Na 2 HPO 4 ) and total cellular extracts were harvested by scraping the attached cells in assay buffer. Floating and adherent cells were then combined and cell lysis was performed through three cycles of freeze/thaw with liquid nitrogen/water bath at room temperature, and samples were then passed through a 27G needle (20e30 strokes). Cellular extracts were centrifuged at 14,000Âg for 5 min and supernatants were transferred to new tubes. Protein content of each sample was determined using the Bradford assay (Bradford, 1976) , using BSA as a standard. To measure caspase 3 and 9-like activities, aliquots of cell extracts containing 25 mg or 50 mg of protein, respectively, were incubated for two hours at 37 C with 100 mM substrate solutions containing Ac-DEVD-pNA, for caspase-3-like activity, or Ac-LEHD-pNA, for caspase-9-like activity. After the incubation period, the absorbance of pNA resulting from substrate cleavage by caspases was read at 405 nm in a Spectramax Plus 384 microplate reader (Molecular Devices, Silicon Valley, CA, USA). The assay was calibrated with known concentrations of pNA, and the results were expressed as % pNA released.
Confocal microscopy
The effect of NEF on mitochondrial superoxide anion generation, DJ m , cell mass and nuclear morphology was evaluated through confocal microscopy, using the probes MitoSOX Red, TMRM þ or Hoechst 33342, respectively. Cells were seeded on 60 cm 2 dishes, at a density of 1.7 Â 10 6 /dish and treated with 20 or 50 mM NEF. After the first 24 h of treatment, cells were trypsinized, centrifuged at 300Âg for 3 min, resuspended in culture medium containing NEF at the respective concentration, and transferred to m-Slide 8 well ibiTreat (Ibidi Martinsried, Germany) at a density of 50,000 cells/ well. Treatment conditions were kept after transfer. At the end of treatment (48 h or 72 h), culture medium was removed and cells were incubated with either a mixture of TMRM þ (150 nM) plus Hoechst 33342 (1 mg/ml) probes or with a mixture of Hoechst 33342 (1 mg/ml) plus MitoSOX Red mitochondrial superoxide indicator (5 mM), prepared in HBSS. Incubation was performed at 37 C for 30 min, in the dark. Cells were observed under a Zeiss LSM 510Meta confocal microscope and images were obtained through LSM Image Browser. Image acquisition and image analysis was performed at the MICC Imaging facility of CNC.
Analysis of gene expression by quantitative real-time PCR
Total RNA was extracted with Aurum™ Total RNA Mini Kit (BioRad, Hercules, CA, USA), following the manufacturer's protocol, and quantified using a Nanodrop 2000 (ThermoScientific, Waltham, MA, USA), confirming that A260/280 was always higher than 1.9. RNA integrity was verified by Experion RNA StdSens kit (Bio-Rad), and RNA was converted into cDNA using the iScript™ cDNA Synthesis Kit (Bio-Rad), following the manufacturer's instructions. RT-PCR was performed using the SsoFast Eva Green Supermix, in a CFX96 real time-PCR system (Bio-Rad), with the primers defined in Table 1 , at 500 nM. Amplification of 25 ng was performed with an initial cycle of 30 s at 95.0 C, followed by 40 cycles of 5 s at 95 C plus 5 s at the annealing temperature (T a ) shown in Table 1 . At the end of each cycle, Eva Green fluorescence was recorded to enable determination of Cq. After amplification, melting temperatures of the PCR products were determined by performing melting curves.
For each set of primers, amplification efficiency was assessed, and no template and no transcriptase controls were run. Relative normalized expression was determined using the CFX96 Manager software (v. 3.0; Bio-Rad), with PUM1 and YWHAZ as reference genes, considered together.
Statistical analysis
Data were expressed as mean ± SEM for the number of experiments indicated in the figure legends. Grouped comparisons were performed using two-way analysis of variance (ANOVA). Multiple comparisons were performed using one-way ANOVA followed by Bonferroni post-hoc test. Significance was accepted with p value < 0.05.
Results
Characterization of NEF impact on HepG2 cell viability
To investigate the effect of NEF on HepG2 cell mass, cells were exposed to NEF concentrations ranging from 0 to 100 mM at different exposure times (0e72 h), and cell mass was evaluated by the SRB assay (Fig. 1A) . The results show that the lowest NEF concentrations tested (5 and 10 mM) did not significantly affect cell mass at any of the exposure times tested. After 24 h of treatment, only cells exposed to the highest NEF concentration (100 mM) presented a significant decrease on cell mass comparatively to cells in the control group. A significant decrease on cell mass was also observed when cells were treated with 20e100 mM NEF for 48 h and 72 h. At the latter time point, treatment with NEF at a 10 mM concentration also elicited a significant decrease on cell mass, comparatively to the control group. At concentrations of 20 mM or higher, NEF seemed to block cell proliferation and induce cell death.
For 5 and 10 mM NEF the doubling times (32.2 and 45.53 h, respectively) were increased in comparison with cells treated with DMSO alone (27.1 h), also suggesting impairment of cell proliferation. At higher concentrations NEF completely blocked cell proliferation.
For follow-up studies, we selected two drug concentrations that did not affect cell mass upon 24 h of treatment, but exhibited different degrees of toxicity for longer exposure periods, in order to uncover biological effects of an acute treatment with this drug.
To evaluate the impact of NEF treatment on cell viability, HepG2 cells were incubated with the fluorescent probes CAM and PI, and analyzed by flow cytometry (Fig. 1B,C) . CAM passively crosses cell membrane and, in viable cells, is converted by intracellular esterases into a green fluorescent form (calcein). Propidium iodide only permeates through damaged cell membranes and intercalates with DNA, displaying red fluorescence only in permeabilized cells.
Quadrants containing positive cells for only one of the dyes were considered either dead cells (detected on quadrant 1: CAM negative/PI positive), or live cells (detected on quadrant 4: CAM positive/ PI negative). Cells presenting both types of fluorescence (quadrant 2: CAM positive/PI positive) were considered permeabilized cells, presenting both damaged plasma membranes and active intracellular metabolism.
A significant increase in the permeabilized cell population and a corresponding decrease in the live cell population were only observed for 50 mM NEF, at 48 and 72 h. At 72 h a decrease in dead cells was also observed in cells incubated with 50 mM NEF.
The effect of NEF on caspases À3 and À9 -like activities was evaluated by following the cleavage of the colorimetric substrates Ac-DEVD-pNA and Ac-LEHD-pNA, respectively (Fig. 1 D,E) . The results showed an increase in caspase-9-like activity in cells treated with 20 mM NEF at 24 and 48 h, and an increase in caspase-3-like activity at 48 h. These observations suggest the activation of the mitochondrial apoptotic pathway. Interestingly, no significant changes were found in the activity of the analyzed caspases for cells treated with 50 mM NEF.
NEF induced changes on nuclear morphology and mitochondrial membrane potential
To assess alterations on nuclear morphology as well as alterations on mitochondrial membrane potential, cells treated with 20 and 50 mM NEF for 48 or 72 h and controls were labeled with Hoechst 33342 and TMRM þ and visualized by confocal microscopy (Fig. 2) . Confocal images revealed a decrease in cell number after treatment with 20 mM and 50 mM NEF for 48 and 72 h, when compared with the control, with a more significant effect for the highest NEF concentration. Labeling with Hoechst 33342, allowed to visualize changes in nuclear morphology in cells treated both NEF concentrations, comparatively to non-treated cells. Cell nuclei exhibited a more irregular shape on cells treated with 20 and 50 mM NEF for 48 h and 72 h, with more obvious changes in nuclear morphology observed in cells treated with 50 mM NEF, for both incubation times. These cells exhibited profound changes in morphology with more rounded and small nuclei, known to characterize apoptotic cells.
NEF effect on mitochondrial membrane potential was analyzed after TMRM þ labeling. TMRM þ accumulates inside mitochondria depending on the DJ m , and polarized mitochondria become labeled with red fluorescence, when TMRM þ is used in nonquenching concentrations (Gerencser et al., 2012 Fig. 1 . Effect of NEF on HepG2 cell viability. A) Cell mass was evaluated by the SRB assay after incubation with increasing NEF concentrations (0e100 mM) for different exposure times (0e72 h), in high-glucose medium. Data represent mean ± SEM of 4e7 different experiments. *p < 0.05, **p < 0.01 and****p < 0.0001 (comparisons to control, 0 mM, by twoway ANOVA followed by Bonferroni post-test). B, C) Cell death was evaluated through flow cytometry, using the combination of CAM and PI probes after B) 48 h or C) 72 h exposure to NEF. Data represent mean ± SEM of dead cell population (CAM negative/PI negative), permeabilized cell population (CAM positive/PI positive) and live cell population (CAM positive/PI negative), for six different experiments. **p < 0.01 e control vs 50 mM NEF, ***p < 0.001 e control vs 50 mM NEF, ****p < 0.0001-control vs 50 mM NEF and #### p < 0.0001e20 mM vs 50 mM NEF (One-way ANOVA followed by Bonferroni post-test). D-G) The activities of effector caspase-3 and initiator caspase À9 were evaluated D,F) 24 h or E,G) 48 h after treatment with 20 mM and 50 mM NEF. Results were expressed as concentration of pNA released per mg protein and calibration was done using known concentrations of pNA. Data represent mean ± SEM of 3e4 different experiments. *p < 0.05 e control vs 20 mM NEF, **p < 0.01 e comparisons to control and ## p < 0.01e20 mM NEF vs 50 mM NEF (One-way ANOVA, followed by Bonferroni post-test).
or 72 h induced a decrease on TMRM þ fluorescence, comparatively to non-treated cells, indicating a decrease in DJ m .
NEF treatment increased mitochondrial superoxide anion levels on HepG2 cells
Considering the above described results, NEF seems to have an effect on mitochondrial membrane potential, as well as on the mitochondrial apoptotic pathway, which may be associated with increased mitochondrial ROS. We then analyzed the levels of mitochondrial superoxide anion by labelling cells with MitoSOX Red, upon treatment with 20 mM NEF for 48 h or 72 h (Fig. 3A) . 
NEF is more toxic in HepG2 cells adapted to rely on OXPHOS
The role of mitochondria on NEF hepatotoxicity was further evaluated on HepG2 cells adapted to grow in OXPHOS medium, which remodels cell metabolism to rely exclusively on OXPHOS for energy (Marroquin et al., 2007) . Under these culture conditions, HepG2 cells were incubated with increasing NEF concentrations for different treatment periods, and cell mass was analyzed by the SRB assay (Fig. 3B) . Results show that these cells were more susceptible to NEF toxicity, suffering significant decreases in cell mass at earlier time points and for lower NEF concentrations, compared to HepG2 cells cultured in glucose medium.
Cell mass was significantly decreased 6 h after treatment with 100 mM NEF, comparatively to cells in the control group (DMSO).
After 24 h of treatment, a significant decrease in cell mass was observed for 10e100 mM NEF, and at 48 or 72 h of treatment all NEF concentrations tested led to a significant decrease in cell mass.
Moreover, 5 mM NEF-treated cells showed a doubling time of 57.9 h, whereas for control cells this was of 38.2 h. Overall our results suggest that high concentrations of NEF block cell proliferation.
NEF-induced changes in gene expression
To evaluate possible changes in gene expression induced by NEF, we analyzed the mRNA levels of three different transcription factors involved in cellular response to toxicants (Fig. 4 AeC) .
FOXO3 belongs to a family of transcription factors that modulate the expression of genes involved in cell survival and metabolism and in the upregulation of antioxidant defenses (Wang et al., 2014) .
Treatment with 20 mM and 50 mM for 24 h resulted in increased FOXO3 expression, comparatively to control cells.
We also analyzed the mRNA levels of FOS and JUN, which belong to the AP-1 transcription factor family and also play a role in cell death regulation (Angel and Karin, 1991) . The results show that treatment with 50 mM NEF significantly increased FOS and JUN expression comparatively to control cells, while no significant differences were found on cells treated with 20 mM NEF.
Additionally, the expression of two genes that encode NOXA (also known as PMAIP1) and PUMA (also known as BBC3) were analyzed. These are two p53-induced pro-apoptotic proteins from the BH3-only group which mediate apoptotic mitochondrial permeabilization and trigger the intrinsic apoptotic pathway (Khoo et al., 2014) (Fig. 4 D,E) .
Treatment with 20 and 50 mM NEF significantly increased the levels of NOXA transcripts, in comparison to non-treated cells. The observed increase was higher in cells treated with 50 mM NEF when compared to the expression observed after treatment with 20 mM
NEF.
PUMA expression has been associated with the activation of p53-dependent apoptosis, followed by growth inhibition, cytochrome c release and activation of caspases À3 and À9. Treatment with 20 and 50 mM NEF for 24 h increased PUMA expression when compared to control. Moreover, the effect of 50 mM NEF on PUMA expression was also significantly higher comparatively to cells treated with 20 mM NEF.
The increase in p53-induced genes suggests the occurrence of DNA damage after exposure to NEF. Thus, we analyzed the expression of two genes associated with DNA repair (Christmann and Kaina, 2013) (Fig. 4 F,G) . The ATR gene encodes the Rad3-related (ATR) protein, a member of the PI3K-related protein kinases (PIKKs) that acts as a primary regulator of the replication stress response. Incubation with 20 mM NEF did not induce significant changes in ATR expression, but a significant decrease in ATR mRNA levels was observed in cells exposed to 50 mM NEF, comparatively to both non-treated and 20 mM NEF-treated cells. We also analyzed the expression of the PCNA gene, which encodes the proliferating cell nuclear antigen (PCNA) protein involved in DNA replication, chromatin remodeling, DNA repair, sister-chromatid cohesion and cell cycle control, with an impact on cell proliferation. Results showed that both concentrations of NEF used (20 mM and 50 mM) led to a decrease in PCNA expression, in agreement with the decrease in proliferation observed with the SRB assay.
Considering NEF effects on mitochondrial function, we investigated whether mitochondrial transcription was affected, by analyzing the levels of three mitochondrial DNA (mtDNA)-encoded transcripts, coding for the respiratory chain subunits ND5, COX1 and ATP8 (Fig. 4 H,I ).
Treatment with 50 mM NEF for 24 h significantly decreased ND5
and COX-1 gene expression when compared to control. ATP8 gene expression was decreased upon NEF treatment with both concentrations tested (20 and 50 mM), when compared to the control group, although significantly less after treatment with the lower NEF concentration, compared to 50 mM NEF.
Discussion
NEF is an antidepressive agent developed by Bristol-Myers Squibb that was widely used in the treatment of depression until it was withdrawn from the pharmaceutical market due to the emergence of liver injury and failure in several NEF-treated patients (Aranda-Michel et al., 1999) .
NEF hepatotoxicity was previously reported to be associated with mitochondrial impairment, due to interference with OXPHOS enzymatic activities (Dykens et al., 2008; Nadanaciva et al., 2007) , increased ROS generation and decreased antioxidant defenses (Dykens et al., 2008) . However, the mechanisms underlying NEFinduced mitochondrial dysfunction in hepatocytes are not completely understood. The understanding of possible mitochondrial liabilities is of high importance as it might allow the improvement of screening of new drug candidates. In this regard, we investigated NEF impact on mitochondrial mechanisms associated with drug cytotoxicity that could be used to predict liabilities of future drug candidates.
We selected two drug concentrations that did not induce toxicity after 24 h of treatment and exhibited different degrees of toxicity for longer exposures in HepG2 cells cultured in regular medium containing glucose. Although both concentrations tested (20 mM and 50 mM) are higher than those found in the plasma of patients treated with NEF (around 1 mM (Barbhaiya et al., 1996; Dykens et al., 2008) ), the use of these concentrations represents an acute treatment protocol that better enables uncovering of biological effects. Moreover, drugs are frequently accumulated in the liver, becoming several times more concentrated in the hepatic tissue compared to the plasma (Chu et al., 2013) . Although data on plasma-to-liver ratio of NEF is not available in the literature, if NEF does accumulate in the liver it could potentially inhibit its own elimination (Dykens et al., 2008; Kostrubsky et al., 2006) , contributing to further increases in tissue drug concentration. As our objective was to use NEF as a model hepatotoxic compound withdrawn from the market, to help predict the toxicity of future drug candidates, we had to find an experimental setting where drug toxicity was manifested.
Our results showed that the lower NEF concentration used in this study (20 mM) decreased cell mass to 0.7 times, at 48 h, and 0.31 times, at 72 h, comparatively to cells treated with DMSO alone.
After 24 h of exposure, 20 mM NEF treatment induced an increase in the activity of the initiator caspase-9, which persisted at 48 h. At this time point (48 h), there was also an increase in the activity of the effector caspase-3, suggesting the activation of the mitochondrial apoptotic pathway.
Nuclei of cells treated with 20 mM NEF appeared smaller and denser, typical of apoptotic cells. Labeling with TMRM þ suggested a small increase in DJ m , and mitochondrial superoxide anion levels appeared to increase. Previous reports have shown that apoptosis may be preceded by mitochondrial hyperpolarization, to which mitochondrial depolarization associated with caspase activation follows (Cao et al., 2007; Giovannini et al., 2002; Iijima et al., 2003; Liu et al., 2005; Sanchez-Alcazar et al., 2000) . In this study, hyperpolarization is only visible in some cells while others are clearly depolarized, indicating different stages of apoptotic engagement among the same cell population. These observations reinforce the role of mitochondrial dysfunction in NEF toxicity for lower NEF concentrations, which was also confirmed in glucose-deprived HepG2 cells adapted to rely on oxidative phosphorylation. In these cells, 20 mM NEF was already toxic after 24 h treatment.
Treatment with the lower NEF concentration decreased cell mass to 0.41 times compared to DMSO, and this toxicity persisted for the other time points. This was accompanied by a decrease in cell mass to 0.22 times for 48 h, and 0.14 times for 72 h, when compared to DMSO, being always lower when compared to the same conditions in cells cultured in glucose-containing medium. These results are in accordance with previous reports (Dykens et al., 2008; Nadanaciva et al., 2007) and are suggestive of mitochondrial involvement in NEF hepatotoxicity. These alterations were accompanied by early gene expression changes. At 24 h, a mild increase in the expression of the gene encoding for the transcription factor FOXO3 and small increases in FOS and JUN transcripts. Transcripts for the p53-induced apoptotic genes NOXA and PUMA were also mildly increased. NOXA and PUMA are p53-inducible pro-apoptotic proteins that belong to the BH3-only family of proteins involved in the activation of the intrinsic apoptotic pathway, either by directly binding and inhibiting Bcl-2 anti-apoptotic proteins, or by the direct activation of Bax and Bak pro-apoptotic proteins (Khoo et al., 2014) .
However, PCNA transcripts were largely decreased, in accordance with the decrease in proliferation observed with the SRB assay. PCNA plays a main role in DNA replication and it is also involved in other cellular processes including chromatin remodeling, DNA repair, sister-chromatid cohesion and cell cycle control, affecting cell proliferation (Strzalka and Ziemienowicz, 2011) .
Mitochondrial DNA-encoded transcript ATP8 was also decreased, although two other mitochondrial transcripts were not affected, indicating that mitochondrial DNA transcription was mildly affected.
The higher NEF concentration (50 mM) decreased cell mass to 0.41 times at 48 h, and 0.21 times at 72 h, comparatively to DMSO alone. After 48 h of exposure, the higher NEF concentration increased the number of permeabilized (apoptotic) cells. At 72 h of exposure, the number of dead cells was significantly decreased.
Interestingly, for this concentration NEF did not increase the activity of caspases-9 or -3 at any of the time points studied. Nonetheless, apoptotic nuclei were also observed for the higher NEF concentration at both treatment times. Cell nuclei appeared smaller and denser, even more than what was observed in cells treated with the lower NEF concentration. The smaller size combined with the denser appearance of nuclei suggests that these cells may have undergone pyknosis, one of the major hallmarks of the apoptotic process, resulting from chromatin condensation (Elmore, 2007; Kerr et al., 1972) . These events are suggestive of the occurrence of caspase-independent apoptosis after exposure to the higher NEF concentration.
Both NEF concentrations (20 mM and 50 mM) and at both treatment times (48 h and 72 h) led to alterations on HepG2 cell mass and on nuclear morphology, comparatively to non-treated cells, consistent with the results obtained in the SRB assay for cells growing in glucose medium, and with previous reports (Dykens et al., 2008) .
A decrease in TMRM þ labeling in cells treated with the higher NEF concentration indicates mitochondrial depolarization. Under these conditions the probability of PTP opening increases and further collapse of Dj m can occur. The decrease in Dj m observed upon NEF treatment can be related with inhibition of OXPHOS complexes, and may be associated with cell death induction through PTP opening and BAX cascade, leading to cytochrome c release (De Giorgi et al., 2002; Ly et al., 2003) . Furthermore, treatment with the higher NEF concentration also increased mitochondrial superoxide levels, in agreement with previous works (Dykens et al., 2008) . In HepG2 cells adapted to rely on oxidative phosphorylation, 50 mM NEF was toxic after 24 h of treatment, decreasing cell mass to 0.18 times compared to DMSO, and this toxicity persisted for the other time points, with cell masses of 0.11 times for 48 h, and 0.07 times for 72 h, which were always lower compared to the same conditions in cells cultured in glucose-containing medium. This is similar to what occurred for the lower NEF concentration tested, indicating that NEF hepatotoxicity also involves mitochondrial dysfunction for higher NEF concentrations (Nadanaciva et al., 2007) . The described alterations were accompanied by several early gene expression changes, more evident, in general, when compared to the lower NEF concentration. After 24 h treatment there was a drastic increase in the expression of genes encoding for the transcription factors FOS and JUN, which compose the activator protein-1 (AP1), involved in the transcription of several genes associated with apoptosis, including TNF-alpha, FAS-L and BAK (Angel and Karin, 1991; Fan and Chambers, 2001) .
Transcripts for the p53-inducible apoptotic genes NOXA and PUMA were also highly increased. PCNA transcripts were significantly decreased, but not as much as observed with the lower NEF concentration. Decrease in PCNA transcripts may enhance the cytotoxic effect of NEF on HepG2 cells compromising normal cell proliferation, Decreased PCNA expression also supports the idea that cell death upon NEF treatment can not only be related with apoptosis induction but also with cell cycle arrest (Maga and Hubscher, 2003) .
ATR transcripts were also significantly decreased. The ATR protein is a primary regulator of the replication stress response, with a main role in viability of replicating human and mouse cells and it is activated every S-phase to regulate replication origin firing, repair stalled replication forks, and prevent early entry into mitosis (Cimprich and Cortez, 2008; Cortez et al., 2001; Shechter et al., 2004) . Decreased ATR expression can compromise the ability of HepG2 cells to repair DNA and to survive to possible DNA lesions induced by NEF. Thus, the induction of apoptosis upon NEF treatment may be related with ROS generation and compromised of OXPHOS function, but may also be associated with a decrease in cellular ability to respond to DNA damage induced by NEF.
Additionally, all the mitochondrial-encoded transcripts tested were also decreased, indicating an impairment of mitochondrial transcription, and suggesting that NEF treatment may compromise normal mitochondrial function by affecting mitochondrial transcription, impairing the normal assembly of respiratory chain complexes and consequently compromising OXPHOS activity. Therefore, NEF treatment can affect the ability of mitochondria to generate ATP and compromise cell survival.
Conclusions
NEF compromises normal mitochondrial and cell function, through a mechanism that results in the increased expression of genes associated with DNA-damage response, antioxidant defense and apoptosis and in the decreased expression of genes encoding proteins with a main role in oxidative phosphorylation, DNA repair, cell proliferation, antioxidant defense and cell cycle progression. Thus, HepG2 cell loss upon NEF treatment seems to be a multidimensional process, involving a set of steps and targets that compromise mitochondrial function and cell survival.
